Skip Navigation

News & Resources

Subscribe to NHLBI Press Releases
May 19, 2015

NHLBI Media Availability: New Form of Interleukin-2 Could Be Fine-Tuned to Fight Disease

WHAT:  Scientists are reporting development of a new way to modify interleukin-2 (IL-2), a substance known as a cytokine that plays key roles in regulating immune system responses, in order to fine-tune its actions.  Harnessing the action of IL-2 in a controllable fashion is of clinical interest with potential benefit in a range of situations, including transplantation and autoimmune disease.

May 5, 2015

NIH statement on World Asthma Day 2015

On World Asthma Day 2015, the National Institutes of Health stands with the international community to renew our commitment to advance our understanding of asthma and develop effective strategies to manage and prevent the disease. Within a broad asthma research portfolio, NIH-supported scientists are making progress in understanding how certain exposures—such as to microbes, allergy-triggering substances (allergens) and pollution—may contribute to the development or worsening of asthma, and are working on new approaches to address these factors.

Subscribe to NHLBI In The News
May 4, 2015 : National Academy of Sciences

The National Academy of Sciences announced today the election of 84 new members and 21 foreign associates from 15 countries in recognition of their distinguished and continuing achievements in original research, including NHLBI's Warren J. Leonard, M.D., chief of the Laboratory of Molecular Immunology and director of the Immunology Center.

March 25, 2015 : UPMC/University of Pittsburgh Schools of the Health Sciences

NHLBI-supported researchers from the University of Pittsburgh School of Medicine have identified a group of genes that appear to play a key role in the development of congenital heart disease, the most common type of birth defect.  The study, conducted in mice, appears in the journal Nature

June 25, 2015 to June 26, 2015
The Natcher Conference Center (Building 45)
The NHLBI Office of the Director will host a Sickle Cell Disease Stakeholders Summer Forum on June 25-26
September 29, 2015 to September 30, 2015
Natcher Conference Center (Building 45), National Institutes of Health, Bethesda, Maryland
The event will bring together experts in stem cell biology, cardiovascular development, translating stem cell biology, cardiac remodelling and inflammation, vascular remodelling and inflammation, and tissue engineering/genome editing/new technologies. The emphasis will be on recent discoveries and trends. We will examine the challenges and critical questions that require answers as the field moves forward to clinical applications. The Symposium’s goals are to help the science and field move forward, to find consensus regarding the translation of stem cell biology and research into a clinical setting, and to inspire participants in their own work.